BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.720
+0.090 (3.42%)
Apr 29, 2026, 10:00 AM EDT - Market open
BioLineRx Employees
As of December 31, 2025, BioLineRx had 24 total employees, including 20 full-time and 4 part-time employees. The number of employees decreased by 4 or -14.29% compared to the previous year.
Employees
24
Change (1Y)
-4
Growth (1Y)
-14.29%
Revenue / Employee
$49,167
Profits / Employee
-$48,958
Market Cap
10.59M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Lunai Bioworks | 29 |
| Imunon | 25 |
| Reviva Pharmaceuticals Holdings | 14 |
| Kiora Pharmaceuticals | 13 |
| Cellectar Biosciences | 11 |
| Aprea Therapeutics | 8 |
| Traws Pharma | 7 |
BLRX News
- 1 day ago - BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) - PRNewsWire
- 21 days ago - BioLineRx (BLRX) Partners in Groundbreaking Glioblastoma Trial - GuruFocus
- 21 days ago - Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma - Business Wire
- 4 weeks ago - BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) - PRNewsWire
- 5 weeks ago - BioLineRx Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Earnings Scheduled For March 23, 2026 - Benzinga
- 5 weeks ago - BioLineRx Reports 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 5 weeks ago - BioLineRx (BLRX) and Others Set to Announce Earnings - GuruFocus